In this context, results from the MIG (Metformin in Gestational Diabetes) trial and other studies suggest that its use in pregnancy is save and has some advantages over insulin (especially being weight neutral and without risk of hypoglycemia) (24, 25). This evidence concerns the gene INS and diabetes mellitus.